Allergan Poised To End 2016 With A 5-Day Rally

Allergan plc Ordinary Shares AGN shares are trading higher by $3.40 at $210.61 in Friday's session.

The issue has traded higher in its last five sessions and six out of its last seven. The one outlier was when it was unchanged on December 22 and 23 ($193.99). Over the seven-day span, the issue has rallied from its December 20 close ($191.33) to $212.45 earlier in today's session.

It has been a tough year for the issue (down 32 percent) from its 2015 year-end close of $312.50. The issue tumbled from the $260 area in July to $184.50 in November, when its deal to be acquired by Teva Pharmaceutics TEVA failed to meet antitrust requirements. The month the deal was announced, Allergan made its all-time high of $340.34.

After a slightly higher open, it retreated only $0.09 to $207.51 before continuing its move higher. The current high marks it highest level since November 11, when it peaked at $216.48.